Answers are grounded in this paper and cite their sources.
Nanoprobe demonstrates targeted imaging of atherosclerotic plaques, implying potential for early disease detection.
A DCy-BOH@BSA-HA nanoprobe can be activated by ROS/viscosity and target atherosclerotic plaques for NIR-II imaging.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: